Be part of the knowledge.™

Global Oncology Academy

The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.

For more information about GOA, visit www.globaloncologyacademy.org.

797

LikeLikedUnlike

46-60 of 123

Managing Brain Metastases Through Multidisciplinary Team Collaboration
MinuteCE®
Managing Brain Metastases Through Multidisciplinary Team Collaboration
- Benjamin Levy, MD
1.00 program credits
MinuteCE®
Inside the Decision: Case-Based Navigation of Brain Metastases in Breast and Lung Cancer
- Barbara O'Brien, MD
- Benjamin Levy, MD
- Melin Khandekar, MD, PhD
- Nadia Harbeck, MD, PhD
1.00 credits 6 episodes
Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC 
MinuteCE®
Sequencing Systemic and Local Therapy in HER2-Overexpressing Metastatic NSCLC 
- Benjamin Levy, MD
- Melin Khandekar, MD, PhD
1.00 program credits
Brain Metastases Management: From Detection to Multidisciplinary Care
MinuteCE®
Brain Metastases Management: From Detection to Multidisciplinary Care
- Barbara O'Brien, MD
1.00 program credits
EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions
MinuteCE®
EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions
- Benjamin Levy, MD
- Melin Khandekar, MD, PhD
1.00 program credits
First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
MinuteCE®
First-Line Management of HR+/HER2-Low Breast Cancer With Brain Metastases
- Barbara O'Brien, MD
- Nadia Harbeck, MD, PhD
1.00 program credits
advertisement
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
CME/CE
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
- Mariana C. Castells, MD, PhD
- Tsewang Tashi, MD
0.25 credits
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
CME/CE
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
- Benjamin Levy, MD
0.25 credits
Addressing Unmet Needs in Metastatic Uveal Melanoma
CME/CE
Addressing Unmet Needs in Metastatic Uveal Melanoma
- Marlana Orloff, MD
- Gregory Daniels, MD, PhD
- Jesse Keller, MD
1.00 credits
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
CME/CE
Patients First: Navigating Asparaginase-Based Treatment in Young Adults With ALL
- Ryan D. Cassaday, MD
- Daniel J. DeAngelo, MD, PhD
1.00 credits
Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
MinuteCE®
Unmet Needs in Endocrine Therapy: Rethinking the HR+/HER2- mBC Treatment Roadmap
- Komal Jhaveri, MD, FACP
1.00 program credits
Spotlight on Asia-Pacific: Practice Beyond Borders
MinuteCE®
Spotlight on Asia-Pacific: Practice Beyond Borders
- Hiraji Iwata, MD, PhD
1.00 program credits
advertisement
The Future of Oral SERDs: Combination Strategies
MinuteCE®
The Future of Oral SERDs: Combination Strategies
- Komal Jhaveri, MD, FACP
1.00 program credits
Routes Reconsidered: A Case-Based Debate in SERD Selection
MinuteCE®
Routes Reconsidered: A Case-Based Debate in SERD Selection
- Giuseppe Curigliano, MD, PhD
- Komal Jhaveri, MD, FACP
1.00 program credits
Spotlight on Europe: Adapting the Evidence
MinuteCE®
Spotlight on Europe: Adapting the Evidence
- Giuseppe Curigliano, MD, PhD
1.00 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended